Skip to content

The Efficacy and Safety of Platelet-rich Fibrin and Platelet Rich Plasma in Female Pattern Hair Loss Patients

A Randomized, Split-head Comparison Study of the Efficacy and Safety of Platelet-rich Fibrin and Platelet Rich Plasma in Female Pattern Hair Loss Patients : A Pilot Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06440655
Acronym
PRF
Enrollment
10
Registered
2024-06-04
Start date
2023-05-30
Completion date
2024-09-30
Last updated
2024-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female Pattern Hair Loss, Platelet-rich Fibrin, Platelet-Rich Plasma

Keywords

female pattern hair loss, platelet-rich plasma, platelet-rich fibrin

Brief summary

The goal of this clinical trial is to compare between platelet-rich fibrin and platelet-rich plasma in female pattern hair loss . The main question\[s\] it aims to answer are: * efficacy between platelet-rich fibrin and platelet-rich plasma * safety between platelet-rich fibrin and platelet-rich plasma Participants will be divided into 2 side of treatment with composed of 1. Platelet rich plasma 2. Platelet rich fibrin

Detailed description

Subject was treated both platelet-rich fibrin and platelet-rich plasma for 3 times which 1 month interval then will be followed up at 4 months and 6 months after last treatment

Interventions

DEVICEPlatelet rich plasma

Subjects were treated by Platelet rich plasma in each side of head (Left or right)

DEVICEPlatelet rich fibrin

Subjects were treated by Platelet rich fibrin in each side of head (Left or right)

Sponsors

Siriraj Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

All subject were injected with PRP and PRF at baseline, 4 weeks and 8 weeks with split-head of sides of injection.

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Age 20-55 years * Female * Subject who was diagnosed with Female pattern hair loss in Ludwig Classification 2 (part width 2-4 centimeters) by Dermatologist

Exclusion criteria

* Pregnancy or Lactation subjects * Subject with history of platelet dysfunction, low platelet, anemia, cirrhosis, cancer, or immunocompromised host * Subject who are active smoking and alcoholism * Subject who has dermatitis, scar or infection at intervention area * Subject who has history of allergy to anesthesia drug * Subject who taking NSAIDs, Hormonal drug, anticoagulants drug * Subject who has psychiatric condition diagnosed by psychiatrist * Subject who are not allowed to take a photo

Design outcomes

Primary

MeasureTime frameDescription
Trichoscanbaseline(week0), 4 months after last treatment(week20), 6 months after last treatment(week28)Average counts and density of hair per 1.5mm\^2

Secondary

MeasureTime frameDescription
The 7-point of doctor subjective global assessmentbaseline(week0),1 month after first treatment(week4), 1 months after second treatment(week8), 4 months after last treatment(week20), 6 months after last treatment(week28)Evaluation of improvement through picture by doctor
The 7-point of patient subjective global assessmentbaseline(week0),1 month after first treatment(week4), 1 months after second treatment(week8), 4 months after last treatment(week20), 6 months after last treatment(week28)Evaluation of improvement through picture by patient
Visual analog scalebaseline(week0), 1 month after first treatment(week4), 1 months after second treatment(week8)pain during intervention

Countries

Thailand

Contacts

Primary ContactRattapon Thuangtong, Asst. Prof.
rattaponthuangtong@yahoo.com+66815533305
Backup ContactNoldtawat Viriyaskultorn, MD
noldtawat.vir@gmail.com+66819228736

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026